Will Compass record a goodwill impairment charge related to the Anywhere acquisition by June 30, 2027?
Current Prediction
Prediction History
Multi-vector favorable Q1 evidence reduces impairment risk: preliminary goodwill share 45% (well below 80% concern threshold), synergies $250M+ actioned with Year-1 target raised to $300M, Q1 EBITDA above guide, credit rating upgrades to B2/B+ with positive outlook, +18% stock reaction reduces market-cap-vs-carrying-value tail. Probability shifts lower from 0.11 to 0.08.
Why This Question Matters
The Consolidation Calibrator identified goodwill impairment within 18 months as a major escalation trigger. The $10B EV deal with a 43x synergy premium will generate substantial goodwill. An impairment charge would be a clear signal that the acquisition price exceeded fair value — a direct test of deal quality and capital allocation discipline. It would escalate ACCOUNTING_INTEGRITY and confirm the more bearish capital deployment assessment. The absence of impairment through mid-2027, while not conclusive, would support the thesis that deal value is intact.
Prediction Distribution
Individual Predictions(9 runs)
Preliminary PPA discloses $2.547B goodwill on $5.65B total purchase consideration — a 45% goodwill share, well below the 80% concern threshold. Synergies are dramatically ahead of plan: $250M+ already actioned in 82 days, Year-1 target raised to $300M, 3-year to $500M. Q1 Adj. EBITDA at $61M (record) above the $15-35M guide; Q2 2026 guide $310-350M implies $1.32B annualized run-rate. Credit agencies independently validated the combined entity (Moody's B2 / S&P B+, both positive outlook, both upgrades vs. Anywhere standalone). Stock +18% post-print reduces the market-cap-vs-carrying-value impairment trigger. Probability shifts lower from 0.11 to 0.08.
While operational evidence is favorable, the 18-month resolution window (through June 2027) requires consideration of forward triggers. Compass's first scheduled annual goodwill impairment test is likely Q4 2026 or Q1 2027. By that time: housing market trajectory, Q3-Q4 2026 actuals, Q1 10-Q PPA finalization, and Q2 2027 9.75% note repayment will all be known. Tail-risk path: severe housing decline (>10% YoY for sustained period), synergy realization shortfall, or unexpected cyclical reversal could trigger impairment indicators. None of these are visible in current data, but they remain possible over the 14 remaining months in the resolution window. 0.09 reflects favorable base case with measured forward-uncertainty preservation.
Compass scenario analysis disclosed at Q1: even at 4.1M existing home sales (claimed trough), $1.0B Adj. EBITDA / $750M unlevered FCF — supports goodwill carrying value across realistic housing scenarios. The 45% goodwill share is significantly more favorable than baseline expectations; preliminary PPA suggests intangibles (which amortize) bear most of the merger premium, reducing the residual goodwill exposure. Combined with credit-agency upgrades, the trifecta (favorable PPA mix + ahead-of-plan synergies + ratings validation) creates a strongly defensible carrying value position. Probability shifts lower to 0.07.
The Q1 print materially de-risks the impairment scenario across multiple vectors: (1) preliminary PPA at 45% goodwill share is well below 80% concern threshold, (2) synergy execution dramatically ahead of plan with $250M+ actioned and Year-1 target raised twice, (3) Q1 Adj. EBITDA above guide and Q2 guide implies $1.32B annualized run-rate, (4) credit-agency upgrades provide independent third-party validation, (5) stock +18% reduces market-cap-vs-carrying-value tail. The 18-month window through June 2027 is short for impairment triggers to develop, especially when execution is exceeding plan. Probability shifts to 0.08.
Operational evidence is uniformly favorable but goodwill impairment can be triggered by reporting-unit-level testing, not just consolidated performance. If the brokerage segment underperforms while franchise segment carries the aggregate, segment-level reporting unit impairment is theoretically possible. Q1 disclosed brokerage Adj. EBITDA $147M / franchise $46M / integrated services $13M — brokerage is healthy. But the resolution window includes 5+ quarters of forward operating performance during which segment-level dynamics could shift. Probability holds at 0.09 to preserve segment-level tail risk.
Sibling-market evidence is strongly supportive: comp-2026-year1-synergies resolved YES early (Brier 0.0324), confirming synergy execution exceeds plan. comp-q1-2026-combined-ebitda resolved NO (Brier 0.0025) — the model ensemble correctly priced low-probability tail outcomes. comp-2026-zillow-trial resolved NO — adverse-event probability calibration validated. The pattern: when execution exceeds plan and structural setup is favorable, the ensemble has been well-calibrated to push probabilities lower. 0.08 reflects this calibration update applied to the goodwill impairment market.
Multiple favorable Q1 vectors: 45% goodwill PPA (below 80% threshold), synergies $250M+ actioned, credit rating upgrades, Q1 EBITDA above guide, +18% stock reaction. Strong support for goodwill carrying value. Probability shifts lower from 0.11 to 0.08.
Strong operational evidence reduces impairment probability but 14 months remain in resolution window for adverse triggers to emerge. First scheduled impairment test Q4 2026 or Q1 2027. Housing market trajectory, Q3-Q4 actuals, Q1 10-Q final PPA all forward unknowns. Probability sits at 0.10 with measured tail preservation.
Compass scenario analysis ($1B EBITDA at 4.1M trough) supports carrying value across realistic scenarios. PPA 45% goodwill + 55% intangibles favorable mix. Synergies ahead of plan. Credit rating upgrades. Stock recovery. All directions favorable — probability drops to 0.07.
Resolution Criteria
Resolves YES if Compass records a goodwill impairment charge of any amount related to the Anywhere Real Estate acquisition in any SEC filing (10-Q or 10-K) for periods through June 30, 2027. Includes interim and annual impairment testing. The charge must be explicitly identified as goodwill impairment in the financial statements or footnotes. Resolves NO if no goodwill impairment charge related to Anywhere is recorded in any filing through the 10-Q for Q2 2027 (expected August-September 2027).
Resolution Source
Compass Inc. SEC filings (10-Q and 10-K) on SEC EDGAR, specifically goodwill and intangible assets footnotes
Source Trigger
Goodwill impairment charge within 18 months of merger close
Full multi-lens equity analysis